Caroline Litchfield net worth and biography

Caroline Litchfield Biography and Net Worth

CFO of Merck & Co., Inc.

Caroline Litchfield is executive vice president and chief financial officer for Merck, responsible for the company’s finance, procurement and real estate operations.

Prior to this role, Caroline served as the company’s treasurer, a position that included responsibility for treasury, tax and investor relations. From 2014 to 2018, Caroline led finance for Human Health, the company’s largest business, overseeing financial operations and reporting in approximately 100 markets.

Previously, Caroline was the vice president and finance lead for the company’s Emerging Markets region when it was established in 2009 following the merger of Merck and Schering-Plough and was instrumental in integrating the two companies. She joined Merck in 1990 in its U.K. business and has held a wide range of positions of increasing responsibility in the company’s country, regional and global finance functions.

Caroline received her Bachelor of Science degree in Mathematics from the University of Leicester and is a fellow of the Chartered Institute of Management Accountants.

How old is Caroline Litchfield?: Ms. Litchfield is currently 55 years old. There are 7 older executives and no younger executives at Merck & Co., Inc.. The oldest executive at Merck & Co., Inc. is Mr. Sanat Chattopadhyay, Executive VP & President of Merck Manufacturing Division, who is 64 years old. Learn More on Caroline Litchfield's age.
How do I contact Caroline Litchfield?: The corporate mailing address for Ms. Litchfield and other Merck & Co., Inc. executives is 2000 GALLOPING HILL ROAD, KENILWORTH NJ, 07033. Merck & Co., Inc. can also be reached via phone at (908) 740-4000 and via email at investor_relations@merck.com. Learn More on Caroline Litchfield's contact information.
Has Caroline Litchfield been buying or selling shares of Merck & Co., Inc.?: Caroline Litchfield has not been actively trading shares of Merck & Co., Inc. during the last quarter. Most recently, Caroline Litchfield sold 18,335 shares of the business's stock in a transaction on Thursday, November 4th. The shares were sold at an average price of $91.00, for a transaction totalling $1,668,485.00. Learn More on Caroline Litchfield's trading history.
Who are Merck & Co., Inc.'s active insiders?: Merck & Co., Inc.'s insider roster includes Sanat Chattopadhyay (Insider), Frank Clyburn (EVP), Robert Davis (CFO), Richard Deluca (EVP), Cristal Downing (Insider), Kenneth Frazier (Insider), Julie Gerberding (EVP), Clark Golestani (EVP), Michael Holston (EVP), Rita Karachun (VP), Caroline Litchfield (CFO), Steven Mizell (EVP), Johannes Oosthuizen (Insider), Joseph Romanelli (Insider), Inge Thulin (Director), Ashley Watson (SVP), and Wendell Weeks (Director). Learn More on Merck & Co., Inc.'s active insiders.
Are insiders buying or selling shares of Merck & Co., Inc.?: During the last year, Merck & Co., Inc. insiders bought shares 1 times. They purchased a total of 2,833 shares worth more than $250,012.25. During the last year, insiders at the sold shares 1 times. They sold a total of 2,361 shares worth more than $209,562.36. The most recent insider tranaction occured on February, 6th when Director Inge G Thulin bought 2,833 shares worth more than $250,012.25. Insiders at Merck & Co., Inc. own 0.1% of the company. Learn More about insider trades at Merck & Co., Inc..
Information on this page was last updated on 2/6/2025.

Caroline Litchfield Insider Trading History at Merck & Co., Inc.

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
11/4/2021	Sell	18,335	$91.00	$1,668,485.00

Caroline Litchfield Buying and Selling Activity at Merck & Co., Inc.

Merck & Co., Inc. Company Overview

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Today's Range

Now: $88.06

$87.31

$89.32

50 Day Range

MA: $92.35

$83.01

$100.72

2 Week Range

Now: $88.06

$81.04

$134.63

Volume

13,807,591 shs

Average Volume

10,313,465 shs

Market Capitalization

$222.44 billion

P/E Ratio

13.08

Dividend Yield

3.42%

Beta

0.35